Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma. - Calafiore, L.; Amoroso, L.; Della Casa Alberighi, O.; Luksch, R.; Zanazzo, G.; Castellano, A.; Podda, M.; Dominici, C.; Haupt, R.; Corrias, M. V.; Garaventa, A. (Annals of Oncology, 2013)